文献速递胃肠外科围术期管理与 ERAS

外科改建胃早期肿瘤内镜黏膜下剥离术的系统综述与荟萃分析

Endoscopic submucosal dissection for early neoplastic lesions in the surgically altered stomach: a systematic review and meta-analysis.
PubMed 文献 · Surg Endosc · 2019-04-08

该系统综述与荟萃分析纳入21项研究共903处残胃或管状胃病变,评估内镜黏膜下剥离术(ESD)在外科改建胃(SAS)中的安全性和有效性。结果显示SAS病变的整块切除率和治愈性切除率与正常胃相似,但管状胃和缝合线病变穿孔风险显著增高。

要点

  • SAS中ESD的整块切除和治愈性切除率与正常胃相当。
  • 管状胃病变穿孔风险显著高于残胃(RR 5.19)。
  • 缝合线病变穿孔风险显著增高(RR 4.55)。

核心结论

  • SAS早期肿瘤ESD安全有效,整块和治愈性切除率与正常胃相似。
  • 缝合线或管状胃病变穿孔风险增加,但可内镜处理。

研究设计与样本

  • 纳入21篇文章,共903处残胃或管状胃病变。
  • SAS定义为胃切除术后残胃和食管切除术后管状胃。
  • 使用Review Manager 5.3软件进行荟萃分析。

主要发现

  • 残胃与管状胃病变的整块切除率无显著差异(RR 0.99,95%CI 0.91-1.08)。
  • 治愈性切除率无显著差异(RR 1.03,95%CI 0.84-1.26)。
  • 出血率无显著差异(RR 1.40,95%CI 0.18-10.72)。
  • 管状胃穿孔风险显著高于残胃(RR 5.19,95%CI 1.27-21.25)。
  • 缝合线病变穿孔风险显著增高(RR 4.55,95%CI 2.13-9.74)。

临床怎么用

  • SAS早期肿瘤可考虑ESD治疗,但需警惕管状胃和缝合线病变的穿孔风险。
  • 穿孔通常可经内镜处理,术前应做好相应准备。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION AND AIM: Endoscopic submucosal dissection (ESD) for early gastric cancer is highly effective and well established. Performing ESD in the surgically altered stomach (SAS) is challenging. The aim of this meta-analysis is to assess the safety and efficacy of ESD for patients with early neoplastic lesions occurring in the SAS with a subgroup analysis of lesions occurring on the suture line compared to non-suture line lesions and outcomes in the remnant stomach compared to the gastric tube. METHODS: We performed a literature search of the PubMed, Embase, and CINAHL electronic databases from January 2000 to November 2017 for articles reporting the safety and efficacy of ESD in the surgically altered stomach. SAS was defined as the remnant stomach following gastrectomy and gastric tube following esophagectomy. Meta-analysis was performed using Review Manager version 5.3 software. RESULTS: A total of 21 articles, with 903 lesions occurring in the remnant stomach or gastric tube, were included in this study. There was no significant difference between en bloc (RR 0.99, 95% CI 0.91-1.08), curative resection (RR 1.03, 95% CI 0.84-1.26), or bleeding rates (RR 1.40, 95% CI 0.18-10.72) between lesions in the remnant stomach and gastric tube. However, perforation was significantly higher in the gastric tube (RR 5.19, 95% 1.27-21.25). Suture line lesions had a significantly higher risk of perforation (RR 4.55, 95% CI 2.13-9.74). CONCLUSION: ESD for early neoplastic lesions occurring in the SAS is a safe and efficacious with similar en bloc and curative resection rates compared to the anatomically normal stomach. ESD for lesions on the suture line or in the gastric tube is associated with an increased risk of perforation which can be managed endoscopically.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Barakat M, Seif M, Abdelfatah MM, et al. Endoscopic submucosal dissection for early neoplastic lesions in the surgically altered stomach: a systematic review and meta-analysis. Surg Endosc. 2019. PMID: 30963259. doi:10.1007/s00464-019-06778-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。